Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-17-002599)

Filing Details

Accession Number:: 0001140361-17-002599
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-01-23 20:48:33
Reporting Period:: 2017-01-05

Filing Date:: 2017-01-23
Accepted Time:: 2017-01-23 20:48:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1437402	Ardelyx Inc.	ARDX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1663000	Paul Korner	C/O Ardelyx, Inc. 34175 Ardenwood Blvd, Suite 200 Fremont CA 94555	Evp, Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-01-05	6,130	$12.95	54,623	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The shares were automatically sold pursuant to the Issuer's 2014 Equity Incentive Award Plan to cover tax liability upon the vesting of outstanding Restricted Stock Units ("RSUs").
Includes 45,565 RSUs. The reporting person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.